Neuromodulation for Patients With Parkinson's Disease
NCT: NCT07767006 · NOT_YET_RECRUITING
Brief Summary
This study will compare different treatment schedules of combined transcranial direct current stimulation (tDCS) and transcranial ultrasound stimulation (TUS) in participants with Parkinson's disease. Participants will be randomly assigned to one of four groups: Standard (10 sessions delivered five times per week for two weeks), Distributed (six sessions delivered three times per week for two weeks), Short (five sessions delivered over one week), or Sham (10 sham sessions delivered five times per week for two weeks).
Frequently Asked Questions
What is Neuromodulation for Patients With Parkinson's Disease?
Neuromodulation for Patients With Parkinson's Disease is a clinical trial registered under NCT07767006. Current status: NOT_YET_RECRUITING.
What is the status of NCT07767006?
The current status of NCT07767006 (Neuromodulation for Patients With Parkinson's Disease) is: NOT_YET_RECRUITING.
When did Neuromodulation for Patients With Parkinson's Disease start?
Neuromodulation for Patients With Parkinson's Disease started on 2026-10-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.